EMULATE
Dead / Abandoned — Abandoned — no statement of use filed (as of 22 Mar 2021)
What this means for you
This application is over — abandoned 22 Mar 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88322229
- Mark type
- Stylized text
- Filed
- 01 Mar 2019
- Published for opposition
- 18 Jun 2019
- Abandoned
- 22 Mar 2021
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical, chemical and biotechnology products, namely, diagnostic and bioactivation preparations and chemical reagents for clinical or medical laboratory use; clinical medical reagents; diagnostic preparations for clinical or medical laboratory use; diagnostic reagents for medical use; biological and chemical preparations for medical use for the treatment for cancer, heart disease, and neurological diseases and medical diagnostic reagents; biological preparations for medical purposes for the treatment of cancer, heart disease, and neurological diseases; aqueous solutions and signals in the nature of diagnostic or therapeutic preparations for medical purposes; biochemicals, namely, antibodies, nucleosides, nucleotides, interferons, solvents, solutions, enzymes, proteins, nucleic acids for medical use
Owner
- EMulate Therapeutics, Inc., Seattle, WA, US
- EMulate Therapeutics, Inc., Seattle, WA, US
Prosecution history
- 22 Mar 2021 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 22 Mar 2021 — ABANDONMENT - NO USE STATEMENT FILED
- 16 Dec 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Dec 2020 — SOU EXTENSION 2 GRANTED
- 13 Aug 2020 — SOU EXTENSION 2 FILED
- 15 Dec 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 29 Oct 2020 — NOTICE OF REVIVAL - E-MAILED
- 29 Oct 2020 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 29 Oct 2020 — PETITION TO REVIVE-GRANTED
- 29 Oct 2020 — TEAS PETITION TO REVIVE RECEIVED
- 14 Sept 2020 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 14 Sept 2020 — ABANDONMENT - NO USE STATEMENT FILED
- 02 Mar 2020 — ASSIGNED TO EXAMINER
- 08 Feb 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Feb 2020 — SOU EXTENSION 1 GRANTED